# FDA Inspection 1059774 - Daiichi Sankyo Altkirch - June 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-altkirch/2b5a349a-ec6f-475f-96af-ba7afe0d2c11
Source feed: FDA_Inspections

> FDA Inspection 1059774 for Daiichi Sankyo Altkirch on June 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059774
- Company Name: Daiichi Sankyo Altkirch
- Inspection Date: 2018-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1234399 - 2022-05-05](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-altkirch/20d9e2e8-38e2-44a4-bf1d-a496a3044d0e)
- [FDA Inspection 1059774 - 2018-06-14](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-altkirch/9de9c4ac-99dd-4e84-bdef-3f301e26b660)
- [FDA Inspection 969549 - 2016-04-22](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-altkirch/58f4a7d1-e5b5-48a9-a586-72ad1706dae3)
- [FDA Inspection 969549 - 2016-04-22](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-altkirch/b6388075-d114-41e5-a3b0-c25dd5d54a64)
- [FDA Inspection 791281 - 2012-06-14](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-altkirch/970c4355-db21-4d85-9873-7372c770eb3a)

Company: https://www.keypedia.com/companies/daiichi-sankyo-altkirch/2edf30bb-5d2c-495c-943c-fe0bb2c4bb25

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c